Chemoinformaics analysis of 12-Octadecadienoic acid
| Molecular Weight | 280.452 | nRot | 14 |
| Heavy Atom Molecular Weight | 248.196 | nRig | 3 |
| Exact Molecular Weight | 280.24 | nRing | 0 |
| Solubility: LogS | -4.16 | nHRing | 0 |
| Solubility: LogP | 6.075 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 53.0014 |
| nHD | 1 | BPOL | 32.9706 |
| QED | 0.318 |
| Synth | 2.356 |
| Natural Product Likeliness | 1.016 |
| NR-PPAR-gamma | 0.972 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.001 |
| HIA | 0.043 |
| CACO-2 | -5.106 |
| MDCK | 0.0000405 |
| BBB | 0.01 |
| PPB | 1.00065 |
| VDSS | 0.722 |
| FU | 0.00512799 |
| CYP1A2-inh | 0.232 |
| CYP1A2-sub | 0.19 |
| CYP2c19-inh | 0.099 |
| CYP2c19-sub | 0.066 |
| CYP2c9-inh | 0.308 |
| CYP2c9-sub | 0.994 |
| CYP2d6-inh | 0.07 |
| CYP2d6-sub | 0.403 |
| CYP3a4-inh | 0.067 |
| CYP3a4-sub | 0.02 |
| CL | 2.067 |
| T12 | 0.863 |
| hERG | 0.043 |
| Ames | 0.001 |
| ROA | 0.01 |
| SkinSen | 0.939 |
| Carcinogencity | 0.042 |
| EI | 0.959 |
| Respiratory | 0.462 |
| NR-Aromatase | 0.091 |
| Antiviral | Yes |
| Prediction | 0.571581 |